Skip to main content
Clinical Trials/NCT05101538
NCT05101538
Completed
Not Applicable

Anorexia Nervosa and it's Effects on Brain Function, Body Metabolism and Their Interaction

Turku University Hospital1 site in 1 country25 target enrollmentNovember 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anorexia Nervosa
Sponsor
Turku University Hospital
Enrollment
25
Locations
1
Primary Endpoint
Changes in brain reward system and metabolism in AN patients
Status
Completed
Last Updated
last year

Overview

Brief Summary

The neuromolecular and metabolic underpinnings of Anorexia Nervosa (AN) are studied using multi-modal molecular (positron emission tomography with two different radioligands) and functional (functional magnetic resonance imaging) neuroimaging in a prospective design. Subjects with AN and normal weight adolescents will be studied with PET and MRI and followed for five years.

Detailed Description

A total of sixty females (30 with AN, 30 healthy controls) are recruited into this prospective study. The subjects will undergo physical examination, body tissue composition measurement, functional and structural MRI of the brain and body, and positron emission tomography (PET) with ligands \[18F\]-FDG, and \[11C\]carfentanil. Subjects' weight and physical condition will be followed up for 5 years. The study will start in August 2020 and end in the fall of 2028.

Registry
clinicaltrials.gov
Start Date
November 1, 2020
End Date
November 1, 2024
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Pirjo Nuutila

Principal Investigator

Turku University Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Any chronic disease or medication that could affect glucose metabolism or neurotransmission
  • History of psychiatric disorders (excl. AN for the corresponding study group)
  • Smoking of tobacco, taking of snuffs, or use of narcotics
  • Abusive use of alcohol

Outcomes

Primary Outcomes

Changes in brain reward system and metabolism in AN patients

Time Frame: 10 years

AN patients and controls are studied using fMRI and PET imaging and followed 10 years. Reward system function is measured using functional MRI and metabolism using 18F-fluorodeoxy glucose and PETCT imaging

Predictive value of baseline body mass index (BMI), functional brain activation and metabolism in AN

Time Frame: 10 y

Results from baseline are combined with follow updata

Study Sites (1)

Loading locations...

Similar Trials